Morgan Stanley Increases Henry Schein (NASDAQ:HSIC) Price Target to $58.00

Henry Schein (NASDAQ:HSIC) had its price objective increased by equities researchers at Morgan Stanley from $55.00 to $58.00 in a report released on Wednesday,Benzinga reports. The firm currently has an “underweight” rating on the stock. Morgan Stanley’s price objective points to a potential downside of 17.21% from the stock’s previous close.

HSIC has been the subject of several other research reports. Evercore ISI boosted their price target on shares of Henry Schein from $83.00 to $90.00 and gave the company an “outperform” rating in a report on Wednesday. UBS Group decreased their target price on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a research report on Wednesday, August 6th. Wells Fargo & Company lifted their price target on Henry Schein from $70.00 to $76.00 and gave the company an “equal weight” rating in a report on Wednesday. JPMorgan Chase & Co. decreased their price target on Henry Schein from $80.00 to $76.00 and set an “overweight” rating for the company in a research note on Thursday, August 7th. Finally, Wall Street Zen cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. Five analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $76.08.

Henry Schein Stock Down 2.7%

Shares of NASDAQ:HSIC opened at $70.06 on Wednesday. The firm has a market cap of $8.50 billion, a PE ratio of 22.60, a price-to-earnings-growth ratio of 2.06 and a beta of 0.84. The company has a fifty day simple moving average of $66.25 and a 200 day simple moving average of $68.65. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein has a 12-month low of $60.56 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $1.38 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.11. The firm had revenue of $3.34 billion during the quarter, compared to analyst estimates of $3.28 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. On average, equities research analysts anticipate that Henry Schein will post 4.74 EPS for the current fiscal year.

Institutional Trading of Henry Schein

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Personalized Indexing Management LLC boosted its holdings in Henry Schein by 3.5% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 4,669 shares of the company’s stock worth $341,000 after buying an additional 157 shares in the last quarter. Equitable Trust Co. lifted its position in shares of Henry Schein by 3.1% during the 2nd quarter. Equitable Trust Co. now owns 5,317 shares of the company’s stock valued at $388,000 after acquiring an additional 158 shares during the last quarter. CW Advisors LLC boosted its stake in shares of Henry Schein by 2.8% during the 2nd quarter. CW Advisors LLC now owns 5,913 shares of the company’s stock worth $432,000 after acquiring an additional 163 shares in the last quarter. TD Asset Management Inc grew its holdings in shares of Henry Schein by 0.8% in the 2nd quarter. TD Asset Management Inc now owns 22,016 shares of the company’s stock worth $1,608,000 after acquiring an additional 164 shares during the last quarter. Finally, Truist Financial Corp raised its position in shares of Henry Schein by 3.3% during the third quarter. Truist Financial Corp now owns 5,540 shares of the company’s stock worth $368,000 after purchasing an additional 175 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.